June 2, 2021 – LivaNova announced June 1 it successfully completed the initial closing of the divestiture of its heart ...
April 23, 2020 – LivaNova PLC said the U.S. Food and Drug Administration (FDA) is now permitting the company to expand ...
February 27, 2020 — The U.S. Food and Drug Administration (FDA) sent a safety communication this week to healthcare to ...
April 30, 2018 — LivaNova announced it completed the sale of its cardiac rhythm management (CRM) business to MicroPort ...
June 28, 2016 — A recent report published by Allied Market Research, titled, "Congestive Heart Failure (CHF) Treatment ...
May 10, 2016 — The first-ever trial using new SonR hemodynamic sensor technology proves to be safely and effectively ...
November 4, 2015 — LivaNova PLC, formerly Sorin Group, launched Platinum, a new range of implantable cardiac ...